bioRxivCancer BiologyPreprint
A natural killer cell gene signature predicts melanoma patient survival
Joseph CursonsiD, Fernando Souza-Fonseca-Guimaraes, Ashley Anderson, Momeneh ForoutaniD, Soroor Hediyeh-ZadehiD, Andreas Behren, Nicholas D. HuntingtoniD, Melissa J Davis
Abstract
Animal models have demonstrated that natural killer (NK) cells can limit the metastatic dissemination of tumors, however their ability to combat established human tumors has been difficult to investigate.\n\nA number of computational methods have been developed for the deconvolution of immune cell types within solid tumors. We have taken the NK cell gene signatures from several tools, then curated and expanded this list using recent reports from the literature. Using a gene set scoring method to investigate RNA-seq data from The Cancer Genome Atlas (TCGA) we show that patients with metastatic cutaneous melanoma have an improved survival rate if their tumor shows evidence of greater NK cell infiltration. Furthermore, these survival effects are enhanced in tumors which have a higher expression of NK cell stimuli such as IL-15, suggesting NK cells are part of a coordinated immune response within these patients. Using this signature we then examine transcriptomic data to identify tumor and stromal components which may influence the penetrance of NK cells into solid tumors.\n\nThese data support a role for NK cells in the regulation of human tumors and highlight potential survival effects associated with increased NK cell activity. Furthermore, our computational analysis identifies a number of potential targets which may help to unleash the anti-tumor potential of NK cells as we enter the age of immunotherapy.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A new highly-specific Natural Killer cell-specific gene signature predicting recurrence in colorectal cancer patients.
C. Shembrey, C. Behrenbruch, … F. Hollande·bioRxiv·Apr 29, 2022
- Evaluation of natural killer cell tumor homing and effector function in response to CDK4/6 and AURKA inhibition in a melanoma tumor-on-a-chip platform
Srija Chakraborty, Connor Durham, … Aleksander Skardal·bioRxiv·Jul 9, 2025
- Interdependence of CTL and NK cells cytotoxicity against melanoma cells
K. S. Friedmann, A. Knoerck, … M. Hoth·bioRxiv·Jun 14, 2020
- Metastatic Single Tumor Cells Evade NK Cell-mediated Killing by Thrombin-mediated Loss of the Activating Ligand CD155/PVR/Necl-5
H. Ichise, S. Tsukamoto, … M. Matsuda·bioRxiv·Jan 15, 2021
- Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers
I. W. Dean, C. Y. Lee, … D. R. Withers·bioRxiv·Aug 10, 2023
- Single-cell transcriptomics reveals that tumor-infiltrating natural killer cells are activated by localized ablative immunotherapy and share anti-tumor signatures induced by immune checkpoint inhibitors
K. Liu, N. Sadeghipour, … W. R. Chen·bioRxiv·May 2, 2023